Table Of Content

Journal of the Neurological Sciences, 119 (1993) 231-232 Elsevier Science Publishers B.V. Author Index (V ol. 119) Abbas, A., see Madkour, O. (119) 8 Fisher, M., Plante, G.M. and Doyle, E.M. Abdel-Kader, A., see Madkour, O. (119) 8 Inhibition of inflammatory cell-mediated myelin oxidation and Akani, F., see Vallat, J.M. (119) 141 interleukin-1B generation by a 21-aminosteroid, U74500A (119) Amaducci, L., see Massacesi, L. (119) 91 189 Arahata, K., see Hayashi, Y.K. (119) 53 Flower, R.J., see Elderfield, A.-J. (119) 146 Arikawa-Hirasawa, E., see Hayashi, Y.K. (119) 53 Artner Dworzak, E., Secnik, P., Parrak, V., Puschendorf, B., Marosi, Gerstenbrand, F., see Artner Dworzak, E. (119) 119 M., Muigg, A., Gerstenbrand, F. and Koller, A. Goto, K., see Hayashi, Y.K. (119) 53 Changes in muscular proteins during simulated microgravity (119) Goto, S., see Shinohara, H. (119) 203 119 Grounds, M.D., see McGeachie, J.K. (119) 169 Grunitzky, E.K., see Vallat, J.M. (119) 141 Baethmann, A., see Staub, F. (119) 79 Gutman, C.R., see Booze, R.M. (119) 110 Ballerini, C., see Massacesi, L. (119) 91 Gutman, C.R., see Booze, R.M. (119) 99 Barbiroli, B., McCully, K.K., Totti, S., Lodi, R., Zaniol, P. and Chance, B. Habbema, J.D.F., see Dippel, D.W.J. (119) 123 Further impairment of muscle phosphate kinetics by lengthening Hamdy, H., see Madkour, O. (119) 8 exercise in DMD/BMD carriers. An in vivo *!P-NMR spec- Hartung, H.-P., see Jung, S. (119) 195 troscopy study (119) 65 Hashizume, Y., see Wakai, M. (119) 18 Bolton, C., see Elderfield, A.-J. (119) 146 Hayashi, Y.K., Engvall, E., Arikawa-Hirasawa, E., Goto, K., Koga, Booze, R.M., Mactutus, C.F., Gutman, C.R. and Davis, J.N. R., Nonaka, I., Sugita, H. and Arahata, K. Frequency analysis of catecholamine axonal morphology in hu- Abnormal localization of laminin subunits in muscular dystro- man brain. I. Effects of postmortem delay interval (119) 99 phies (119) 53 Booze, R.M., Mactutus, C.F., Gutman, C.R. and Davis, J.N. Higuchi, I., see Kanazawa, H. (119) 121 Frequency analysis of catecholamine axonal morphology in hu- Hirai, S., see Mizuno, Y. (119) 43 man brain. II. Alzheimer’s disease and hippocampal sympathetic Horst, G., see Kuks, J.B.M. (119) 183 ingrowth (119) 110 Huitinga, I., see Jung, S. (119) 195 Boysen, G., see Meden, P. (119) 209 Igakura, T., see Kanazawa, H. (119) 121 Calcutt, N.A., Mizisin, A.P. and Yaksh, T.L. Ijichi, S., see Kanazawa, H. (119) 121 Impaired induction of vasoactive intestinal polypeptide after sci- Inagaki, T., see Shinohara, H. (119) 203 atic nerve injury in the streptozotocin-diabetic rat (119) 154 Inaguma, Y., see Shinohara, H. (119) 203 Chance, B., see Barbiroli, B. (119) 65 lotti, S., see Barbiroli, B. (119) 65 Chiba, S., see Tachi, N. (119) 180 Cohen, R., see Matthew, E. (119) 134 Jung, S., Huitinga, I., Schmidt, B., Zielasek, J., Dijkstra, C.D., Toyka, Davis, J.N., see Booze, R.M. (119) 110 K.V. and Hartung, H.-P. Davis, J.N., see Booze, R.M. (119) 99 Selective elimination of macrophages by dichlormethylene Denis, F., sée Vallat, J.M. (119) 141 diphosphonate-containing liposomes suppresses experimental au- Dijksterhuis, J., see Kuks, J.B.M. (119) 183 toimmune neuritis (119) 195 Dijkstra, C.D., see Jung, S. (119) 195 Diop, G., see Vallat, J.M. (119) 141 Kanazawa, H., Ijichi, S., Eiraku, N., Igakura, T., Higuchi, I., Naka- Dippel, D.W.J. and Habbema, J.D.F. gawa, M., Kuriyama, M., Tanaka, S. and Osame, M. Probabilistic diagnosis of normal pressure hydrocephalus and Behcet’s disease and Sjégren syndrome in a patient with HTLV- other treatable cerebral lesions in dementia (119) 123 I-associated myelopathy (119) 121 Doyle, E.M., see Fisher, M. (119) 189 Kato, K., see Shinohara, H. (119) 203 Dumas, M., see Vallat, J.M. (119) 141 Kempski, O., see Staub, F. (119) 79 King, A.C., see Matthew, E. (119) 134 Eiraku, N., see Kanazawa, H. (119) 121 Klingelhofer, J., see Sander, D. (119) 1 Elderfield, A.-J., Bolton, C. and Flower, R.J. Koga, R., see Hayashi, Y.K. (119) 53 Lipocortin 1 (annexin 1) immunoreactivity in the cervical spinal Koller, A., see Artner Dworzak, E. (119) 119 cord of Lewis rats with acute experimental allergic en- Kowall, N.W., see Leifer, D. (119) 217 cephalomyelitis (119) 146 Kuks, J.B.M., Limburg, P.C., Horst, G., Dijksterhuis, J. and Ooster- Elwan, H., see Madkour, O. (119) 8 huis, H.J.G.H. Elwan, O., see Madkour, O. (119) 8 Antibodies to skeletal muscle in myasthenia gravis. Part 1. Diag- Engvall, E., see Hayashi, Y.K. (119) 53 nostic value for the detection of thymoma (119) 183 Evans, K., see Wierzbicki, A.S. (119) 85 Kuriyama, M., see Kanazawa, H. (119) 121 932 Lascelles, P.T., see Wierzbicki, A.S. (119) 85 Pavanello, R.C.M., see Vainzof, M. (119) 38 Leifer, D. and Kowall, N.W. Peters, J., see Staub, F. (119) 79 Immunohistochemical patterns of selective cellular vulnerability Plante, G.M., see Fisher, M. (119) 189 in human cerebral ischemia (119) 217 Puschendorf, B., see Artner Dworzak, E. (119) 119 Limburg, P.C., see Kuks, J.B.M. (119) 183 Liuzzi, G.M., see Massacesi, L. (119) 91 Ramiandrisoa, H., see Vallat, J.M. (119) 141 Lodi, R., see Barbiroli, B. (119) 65 Riccio, P., see Massacesi, L. (119) 91 Mackert, B., see Staub, F. (119) 79 Sander, D. and Klingelh6fer, J. Mactutus, C.F., see Booze, R.M. (119) 110 Cerebral vasospasm following post-traumatic subarachnoid hem- Mactutus, C.F., see Booze, R.M. (119) 99 orrhage evaluated by transcranial Doppler ultrasonography (119) Madkour, O., Elwan, O., Hamdy, H., Elwan, H., Abbas, A., Taher, 1 M. and Abdel-Kader, A. Sasaki, S. and Maruyama, S. Transient ischemic attacks: electrophysiological (conventional and A fine structural study of Onuf’s nucleus in sporadic amyotrophic topographic EEG) and radiological (CCT) evaluation (119) 8 lateral sclerosis (119) 28 Mancardi, L., see Massacesi, L. (119) 91 Sato, T., see Tachi, N. (119) 180 Marosi, M., see Artner Dworzak, E. (119) 119 Schmidt, B., see Jung, S. (119) 195 Maruyama, S., see Sasaki, S. (119) 28 Schut, L., see Matthew, E. (119) 134 Massacesi, L., Vergelli, M., Zehetbauer, B., Liuzzi, G.M., Olivotto, Secnik, P., see Artner Dworzak, E. (119) 119 J., Ballerini, C., Uccelli, A., Mancardi, L., Riccio, P. and Ama- Sereghy, T., see Meden, P. (119) 209 ducci, L. Shinohara, H., Inaguma, Y., Goto, S., Inagaki, T. and Kato, K. Induction of experimental autoimmune encephalomyelitis in rats @B crystallin and HSP28 are enhanced in the cerebral cortex of and immune response to myelin basic protein in lipid-bound form patients with Alzheimer’s disease (119) 203 (119) 91 Staub, F., Mackert, B., Kempski, O., Peters, J. and Baethmann, A. Matthew, E., Nordahl, T., Schut, L., King, A.C. and Cohen, R. Swelling and death of neuronal cells by lactic acid (119) 79 Metabolic and cognitive changes in hereditary ataxia (119) 134 Sugita, H., see Hayashi, Y.K. (119) 53 McCully, K.K., see Barbiroli, B. (119) 65 McGeachie, J.K., Grounds, M.D., Partridge, T.A. and Morgan, J.E. Tachi, N., Ohya, K., Chiba, S. and Sato, T. Age-related changes in replication of myogenic cells in mdx mice: Unstable DNA in a patient with a severe form of congenital quantitative autoradiographic studies (119) 169 myotonic dystrophy (119) 180 Meden, P., Overgaard, K., Sereghy, T. and Boysen, G. Taher, M., see Madkour, O. (119) 8 Enhancing the efficacy of thrombolysis by AMPA receptor block- Takahashi, A., see Wakai, M. (119) 18 ade with NBQX in a rat embolic stroke model (119) 209 Takata, R.1., see Vainzof, M. (119) 38 Mizisin, A.P., see Calcutt, N.A. (119) 154 Tanaka, S., see Kanazawa, H. (119) 121 Mizuno, Y., Nonaka, I., Hirai, S. and Ozawa, E. Toyka, K.V., see Jung, S. (119) 195 Reciprocal expression of dystrophin and utrophin in muscles of Duchenne muscular dystrophy patients, female DMD-carriers Uccelli, A., see Massacesi, L. (119) 91 and control subjects (119) 43 Morgan, J.E., see McGeachie, J.K. (119) 169 Muigg, A., see Artner Dworzak, E. (119) 119 Vainzof, M., Passos-Bueno, M.R., Takata, R.I., Pavanello, R.C.M. and Zatz, M. Nakagawa, M., see Kanazawa, H. (119) 121 Intrafamilial variability in dystrophin abundance correlated with difference in the severity of the phenotype (119) 38 Nonaka, I., see Hayashi, Y.K. (119) 53 Vallat, J.M., Dumas, M., Grunitzky, E.K., Akani, F., Diop, G., Nonaka, I., see Mizuno, Y. (119) 43 Ramiandrisoa, H. and Denis, F. Nordahl, T., see Matthew, E. (119) 134 Nukada, H. Lack of association between peripheral neuropathy and HTLV-I infection in West Africa. Epidemiological, serological and nerve The susceptibility of rat diabetic nerve to ischemia: increased or biopsy study (119) 141 decreased? (119) 162 Vergelli, M., see Massacesi, L. (119) 91 Ohya, K., see Tachi, N. (119) 180 Olivotto, J., see Massacesi, L. (119) 91 Wakai, M., Takahashi, A. and Hashizume, Y. Ono, S. and Yamauchi, M. A histometrical study on the globus pallidus in Huntington’s Collagen fibril diameter and its relation to cross-linking of colla- disease (119) 18 gen in the skin of patients with amyotrophic lateral sclerosis (119) Wierzbicki, A.S., Patel, N., Evans, K. and Lascelles, P.T. 74 Copper-64 metabolism in two patients with non-Wilsonian move- Oosterhuis, H.J.G.H., see Kuks, J.B.M. (119) 183 ment disorders and copper deficiency (119) 85 Osame, M., see Kanazawa, H. (119) 121 Overgaard, K., see Meden, P. (119) 209 Yaksh, T.L., see Calcutt, N.A. (119) 154 Ozawa, E., see Mizuno, Y. (119) 43 Yamauchi, M., see Ono, S. (119) 74 Parrak, V., see Artner Dworzak, E. (119) 119 Zaniol, P., see Barbiroli, B. (119) 65 Partridge, T.A., see McGeachie, J.K. (119) 169 Zatz, M., see Vainzof, M. (119) 38 Passos-Bueno, M.R., see Vainzof, M. (119) 38 Zehetbauer, B., see Massacesi, L. (119) 91 Patel, N., see Wierzbicki, A.S. (119) 85 Zielasek, J., see Jung, S. (119) 195 Journal of the Neurological Sciences, 119 (1993) 233-234 Elsevier Science Publishers B.V. Subject Index (V ol. 119) Age, (119) 169 Experimental diabetes, (119) 162 Age at onset, (119) 183 Experimental thromboembolism, (119) 209 Alzheimer’s disease, (119) 203 AMPA receptor antagonist, (119) 209 Female DMD-carrier, (119) 43 Amyotrophic lateral sclerosis, (119) 28, (119) 74 [!SF]-2-fluoro-2-deoxy-p-glucose, (119) 134 Annexin, (119) 146 Frontal cortex, (119) 99, (119) 110, (119) 134 Anti-muscle antibodies, (119) 183 Fukuyama congenital muscular dystrophy, (119) 53 Antioxidant, (119) 189 Autopsy, (119) 217 Glioma cell, (119) 79 Autoradiography, (119) 169 Globus pallidus, (119) 18 Axonal transport, (119) 154 Basal lamina, (119) 53 Head injury, (119) 1 a@B Crystallin, (119) 203 Heat shock protein, (119) 203 Becker dystrophy, (119) 65 Hereditary ataxia, (119) 134 Behcet’s disease, (119) 121 Hippocampus, (119) 99, (119) 110, (119) 217 Blood vessel, (119) 146 Histidinohydroxylysinonorleucine (HHL), (119) 74 Histometry, (119) 18 HTLV-I-associated myelopathy, (119) 121, (119) 141 Calcarine cortex, (119) 99, (119) 110 Huntington’s disease, (119) 18 Cell replication, (119) 169 Hydrocephalus, (119) 123 Cell swelling, (119) 79 Hypotonia, (119) 180 Cell viability, (119) 79 Cerebellum, (119) 134 Cerebral blood flow, (119) 209 Immunoassay, (119) 203 Cerebral cortex, (119) 203, (119) 217 Immunocytochemistry, (119) 99 Cerebral glucose metabolism, (119) 134 Immunohistochemistry, (119) 203, (119) 217 Cerebral ischemia, (119) 217 Immunostaining, (119) 110 Citric acid extract, (119) 183 Immunotherapy, (119) 195 Clinical outcome, (119) 1 Inflammatory cell, (119) 189 Collagen, (119) 74 Intracranial pressure, (119) 1 Computed tomography, (119) 123 Intrafamilial variability, (119) 38 Conventional electroencephalography (EEG), (119) 8 Irradiation, (119) 169 Copper, (119) 85 Ischemic injury, (119) 162 Corticosterone, (119) 146 Cross-linking, (119) 74 Lactacidosis, (119) 79 Crush injury, (119) 154 Laminin, (119) 53 Lipocortin, (119) 146 Decision analysis, (119) 123 Liposomes, (119) 195 Dementia, (119) 123 Lymphocyte, (119) 146 Demyelination, (119) 195 Diabetic neuropathy, (119) 154, (119) 162 Macrophage, (119) 146, (119) 195 Diagnosis, (119) 183 Merosin, (119) 53 Dichlormethylene diphosphonate, (119) 195 Motor neuron disease, (119) 28 cDNA25, (119) 180 Mouse, mdkx, (119) 169 Duchenne dystrophy, (119) 38, (119) 65 Movement disorder, (119) 85 Duchenne muscular dystrophy, (119) 43 Multiple sclerosis, (119) 91 Dystrophin, (119) 38, (119) 43, (119) 53, (119) 65 Muscle injury, (119) 65 Dystrophin-related protein (DRP), (119) 43 Muscle protein, (119) 119 Muscular dystrophy, (119) 53 Eccentric exercise, (119) 65 Myasthenia gravis, (119) 183 Endothelial cell, (119) 146 Myelin, (119) 91, (119) 189 Expanding unstable DNA, (119) 180 Myelin basic protein, (119) 91 Experimental allergic encephalomyelitis, (119) 146 Myelin lipids, (119) 91 Experimental autoimmune encephalomyelitis, (119) 91 Myogenesis, (119) 169 Experimental autoimmune neuritis, (119) 195 Myopathy, (119) 65 234 NBOX, (119) 209 Skin, (119) 74 Nerve biopsy, (119) 141 Streptozotocin, (119) 162 Nerve ischemia, (119) 162 Stroke, (119) 209 Neuro-2A neuroblastoma cell, (119) 79 Subarachnoid hemorrhage, (119) 1 Neuromuscular junction, (119) 43 *!P-NMR spectroscopy, (119) 65 Thrombolytic therapy, (119) 209 Noradrenergic, (119) 110 Thymoma, (119) 183 Thymus, (119) 183 Onuf’s nucleus, (119) 28 Topographic EEG analysis, (119) 8 Transcranial Doppler, (119) 1 Pathology, (119) 18 Transient ischemic attack (TIA), (119) 8 Polymorphism, (119) 180 Tropical neuropathy, (119) 141 Positron emission tomography, (119) 134 Tropical spastic paraplegia, (119) 141 Tyrosine hydroxylase, (119) 99, (119) 110 Premature birth, (119) 180 Rapid autopsy, (119) 99 Ultrastructure, (119) 28 Reciprocal expression, (119) 43 Utrophin, (119) 43 Recombinant tissue plasminogen activator, (119) 209 Regeneration, (119) 154 Vasoactive intestinal polypeptide, (119) 154 Simulated microgravity, (119) 119 Vasospasm, (119) 1 Sjogren sydrome, (119) 121 Skeletal muscle, (119) 169 Wilson’s disease, (119) 85